LY-367,265

From WikiMD.com Medical Encyclopedia

LY-367,265 is a drug that acts as a serotonin and norepinephrine reuptake inhibitor, and 5-HT1A receptor agonist. It was developed by Eli Lilly for the treatment of depression and anxiety disorders, but was discontinued in the early stages of clinical trials due to poor bioavailability.

Pharmacology[edit | edit source]

LY-367,265 is a serotonin-norepinephrine reuptake inhibitor (SNRI) and a 5-HT1A receptor agonist. It works by inhibiting the reuptake of serotonin and norepinephrine, two neurotransmitters in the brain that are involved in mood regulation. By blocking their reuptake, LY-367,265 increases the levels of these neurotransmitters in the brain, which can help to alleviate symptoms of depression and anxiety.

In addition to its SNRI activity, LY-367,265 also acts as an agonist at the 5-HT1A receptor. This receptor is involved in a variety of functions in the brain, including the regulation of mood, anxiety, and sleep. By activating this receptor, LY-367,265 may provide additional benefits in the treatment of depression and anxiety disorders.

Clinical Trials[edit | edit source]

LY-367,265 was developed by Eli Lilly and entered into clinical trials for the treatment of depression and anxiety disorders. However, the drug was discontinued in the early stages of development due to poor bioavailability. Bioavailability refers to the extent and rate at which a drug is absorbed and becomes available at the site of drug action. Despite its promising pharmacological profile, LY-367,265 was not able to be effectively absorbed and utilized by the body, limiting its therapeutic potential.

See Also[edit | edit source]

References[edit | edit source]


FlattenedRoundPills.jpg
This article is a stub related to pharmacology. You can help WikiMD by expanding it!
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD